This finding suggests that the high capability for DENV infection in human monocytes in vivo may increase viral yield, which may create more problems in the efficient clearance of the virus and thus increase the likelihood of a severe clinical outcome of dengue in G6PD-deficient patients. Here, G6PD is linked to dengue disease.